SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today three new Contract Research ...
Mesenchymal stromal cells (MSCs) offer significant potential for treating a wide range of human musculoskeletal disorders, encompassing conditions such as cartilage defects, osteoarthritis, ...
Biology software developer Phylo Inc. today announced that it has raised $13.5 million in seed funding. Andreessen Horowitz led the round with Anthology Fund, a $100 million investment vehicle created ...
Drug discovery is becoming more personalized, and the methods used to generate therapeutic insights are advancing alongside it. Spatial biology tools let researchers interrogate tissue function, cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results